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Activation of the alternative pathway of complement by cellulosic
hemodialysis membranes. Compared to cellulose acetate, hemodialysis
with cuprophan membranes is associated with greater activation of the
alternative pathway of complement. Previous studies have shown that
this difference is not due to a greater number of potential covalent
binding sites for activated C3 on cuprophan. To investigate further the
factors that influence complement activation by hemodialysis mem-
branes, proteins were eluted from serum-treated cuprophan and cellu-
lose acetate membranes with hydroxylamine at alkaline pH and ana-
lyzed by SDS-PAGE and Western blot. Approximately 23 times more
total protein was removed from cellulose acetate. Virtually all the C3 in
the cellulose acetate eluate was in the form of inactive fragments C3c
and C3dg. In contrast, the functionally active form of C3 (C3b) was a
prominent constituent of the cuprophan eluate. The binding of factor B
(precursor of the catalytic subunit of the C3 convertase) and factor H
(regulatory protein of C3 activation) to serum-treated membranes was
also analyzed. By Scatchard's method, the affinity constant at equilib-
rium for factor B binding (KB) to the two types of membranes was not
significantly different; however, there were approximately four times
more factor B binding sites on the cuprophan than on the cellulose
acetate. For cuprophan, the number of factor B binding sites was 1.6
times greater than the number of factor H binding sites. These studies
demonstrate that a portion of the C3b molecules that bind to cuprophan
are protected from degradation, and suggest that the complement
activating capacity of hemodialysis membranes is determined by bio-
chemical properties that modulate both the binding of serum proteins to
the membrane and the interactions of the endogenous regulatory
proteins with membrane-associated C3b.
Cellulosic membranes are the types most frequently used for
routine clinical hemodialysis. The prototypical cellulosic mem-
brane, cuprophan, is prepared by regeneration of cellulose
obtained from the matrix of plant cell walls [1]. Cellulose is a
polymer of glucosan rings with three hydroxyl groups on each
ring. Unlike cuprophan, cellulose acetate membranes have the
majority (approximately 70%) of the hydroxyl groups deriva-
tized with acetyl residues.
Hemodialysis using cellulosic membranes is associated with
complement activation via the alternative pathway [2—4], and
the consequent generation of biologically-active complement
peptides (C3a, C5a and CSadesArg) [3, 4] appears to contribute to
dialysis-related neutropenia [3—51, pulmonary artery hyperten-
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sion [6, 7] and probably to the production of interleukin-l [8].
Compared to cuprophan, cellulose acetate membranes have
been shown to be associated with significantly less complement
activation [9, 10]. It has been proposed that this difference in
complement activating capacity is due to the presence of a
larger number of free hydroxyl groups on the cuprophan
membrane that would provide a source for nucleophilic attack
on the thiolester bond of nascent C3b [11]. According to this
hypothesis, complement activation on cellulose acetate mem-
branes is attenuated because derivatization of hydroxyl groups
with acetyl residues blocks C3b acceptor sites. Recent investi-
gations, however, have shown that the activated C3 which is
associated with cellulosic membranes is non-covalently bound
[12]. The latter observations suggest that the complement
activating properties of dialysis membranes are not determined
by the availability of potential covalent binding sites for acti-
vated C3b.
Activation of the alternative pathway of complement (APC)
on particulate surfaces is initiated following binding of C3b [13,
14], which creates a nidus for the formation of the C3 and CS
convertase of the APC [15, 16]. The molecular basis for
differences in APC activity on several biological surfaces have
been reported. While greater efficiency of binding of nascent
C3b may in some instances contribute to APC activation [17], in
most cases the capacity of a particulate surface to support APC
activation is determined primarily by biochemical properties
that influence the binding of factors B and H to C3b [18—21].
Factor B is the enzymatic subunit of both the C3 (C3bBb) and
the CS (C3bBbC3b) convertase of the APC [22]. Thus binding of
factor B to C3b results in activation of the APC. Factor H
regulates APC activity in three ways. First by binding to C3b,
factor H displaces bound Bb. Second, binding of factor H to
C3b inhibits further binding of factor B. Third, factor H serves
as a cofactor for the enzymatic degradation of C3b to iC3b by
factor I. Thus, APC activity is inhibited under circumstances in
which the affinity of C3b for factor H is greater than that for
factor B.
We proposed that the interactions of the APC regulatory
proteins, factors B and H, with membrane-associated C3b are
primary determinants of the complement activation potential of
cellulosic hemodialysis membranes. Accordingly, the binding
of factors B and H to C3b associated with cuprophan and
cellulose acetate membranes following incubation with serum
was analyzed. The results of these studies suggest that cu-
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prophan activates more complement than cellulose acetate
because a greater portion of C3b that binds to cuprophan
membranes maintains its functional activity longer.
Methods
Buffers and solutions
All chemicals were of a reagent grade. The following buffers
and solutions were employed: phosphate-buffered saline, con-
sisting of 10 m sodium phosphate and 145 mM NaCI, pH 7.4
(PBS); PBS with 5 mM MgCl2 (PBS); PBS containing 5%
(wt/vol) bovine serum albumin (Sigma Chemical Co., St. Louis,
Missouri, USA) and 2 mrs MgCl2 (PBS/A); PBS containing I
mM phenylmethylsulfonyl fluoride (PMSF, Sigma Chemical
Co.) and 20 mrvi EDTA (PBS-PE); Tris-buffer consisted of 10
mM Tris, pH 7.4; 1 M hydroxylamine monohydrochloride
(Sigma Chemical Co.) containing 1 mi PMSF and 20 mss
EDTA, titrated to pH 10.5 (NH2OH-PE); gelatin veronal buff-
ered saline contained 0.1% gelatin, 140 ms'i NaCl, 5 m'vi sodium
barbital, pH 7.4 (GVB); GVB containing 0.15 msi CaCI2 and 0.5
mM MgCl (GVB); GVB containing 10 mrvi EDTA (GVB-
EDTA); normal human serum (NHS); NHS supplemented with
2 msi Mg; NHS incubated with 20 mM EDTA for five
minutes prior to use (NHS-EDTA).
Complement proteins and antibodies
Human C3 [23], C3c (24), C3dg [24], factors B [25], H [26],
and D [26] and cobra venom factor (CVF) [27, 28] were isolated
according to published methods. Polyclonal goat anti-human C3
IgG, goat anti-human factor H IgG and goat anti-human factor
B IgG were purchased from Atlantic Antibodies (Scarborough,
Maine, USA). Affinity-purified peroxidase-conjugated porcine
anti-goat IgG was purchased from TAGO, Inc. (Burlingame,
California, USA).
Cellulosic hemodialysis membranes
Cuprophan and cellulose acetate hemodialysis membranes (in
sheet format) were supplied by Dr. U. Baurmeister and Dr. J.
Vienken (Akzo, formerly Enka AG, Wuppertal, FRG). Circular
discs of 1 cm diameter were used in the experiments described
herein. Surface analysis by electron spectrometer (HP 5950B,
Hewlett Packard, Palo Alto, California, USA) showed that
approximately 70% of the hydroxyl groups were acetylated on
the cellulose acetate membranes.
Analysis of proteins eluted from hemodialysis membranes
One hundred pieces of 1 cm diameter disc of cuprophan or
cellulose acetate were incubated at 37°C with 2.5 ml of NHS
After 30 minutes, the membranes were washed three times with
PBS-PE. Proteins were eluted by incubating the membranes at
37°C with 4 ml of NH2OH-PE. After 30 minutes the supernate
was dialyzed at 4°C against Tris buffer using Spectropor dialysis
tubing (Spectrum Medical Industries, Inc., Los Angeles, Cali-
fornia, USA) with a molecular weight exclusion limit of 2 kDa.
After subsequent lyophilization, the proteins were resuspended
in 250 j.d of Tris buffer and analyzed by SDS-PAGE [29] under
reducing conditions in a 5 to 15% linear gradient gel. After
fixation, the gels were stained with Coomassie Brilliant blue
R-250 (Bio-Rad Laboratories, Richmond, California. USA).
Western blots were developed with anti-C3, anti-factor B or
anti-factor H as the primary antibodies as previously described
[30]. For consistency, a fixed quantity (35 g) of NHS or
membrane eluates were analyzed in the different blots.
Apparent molecular weights were calculated according to the
method of Weber and Osborn [31] using standards purchased
from Bio-Rad Laboratories, and the established Mrof the a and
/3 chains of C3 (125 and 75 kDa, respectively) [22], the a chain
fragments of C3c (43 and 40 kDa) [32], C3dg (41 kDa) [32],
factor H (150 kDa) [26], factor B (93 kDa) and the Bb (60 kDa)
and Ba (33 kDa) fragments of factor B [25].
Generation of factor B fragments
An aliquot of 100 p1 of factor B (200 g/ml) was incubated for
30 minutes at 37°C with 100 p1 of CVF (200 g/m1) and either 25
p1 factor D or 25 p1 PBS. The final volume of the reaction
mixture was adjusted to 275 tl by the addition of 50 p1 PBS.
A third reaction mixture contained 100 p1 of factor B and 175 p1
ofPBS
Determination of residual C3 con vertase activity on
hemodialysis membranes following incubation with NHS
Five pieces of membrane were incubated at 37°C with 500 p1
of either NHS or NHS-EDTA. After 30 minutes, the mem-
branes were washed three times with PBS. The NHS-treated
membranes were then incubated at 37°C with 50 tg of purified
native C3 in 200 p1 GVB; the NHS-EDTA-treated mem-
branes were incubated with the same amount of C3 in 200 p1 of
GVB-EDTA. After 30 minutes, the C3a present in the supernate
was quantitated by radioimmunoassay (Amersham, Arlington
Heights, Illinois, USA). Specific C3a generation by the mem-
branes during the incubation with NHS was calculated by
subtracting the background value (incubation with NHS-
EDTA) from the total amount generated (incubation with
NHS).
Binding of factor B and factor H to NHS-treated membranes
Factors B and H were radiolabeled to a specific activity of 2
to 8 x i05 cpm/g with 1251 as Nal (Amersham Corp.) using the
lactose peroxidase method [33]. To determine if their binding
affinities were affected by the iodination, labeled and unlabeled
factor B or factor H were incubated with sheep erythrocytes
bearing human C3b (EC3b) [34]. The concentration of factor B
or H was kept constant, but the proportion of the total input
that was radiolabeled was varied. For both factor B and factor
H, the amount of bound radiolabeled protein increased linearly
when the ratio of labeled: unlabeled protein was increased in
the input. These results indicated that the affinities of the
labeled and unlabeled proteins for C3b were equivalent.
Initial attempts to analyze binding of factors B and H to C3b
deposited onto cuprophan and cellulose acetate membranes
using isolated components of the APC were unsuccessful be-
cause, unlike the situation with erythrocytes [35] and numerous
other biological surfaces [36], specific binding of C3b to the
dialysis membranes was not observed.
Inasmuch as activated C3 is deposited onto cellulosic mem-
branes following incubation with NHS [12], binding of radiola-
beled factors B and H to NHS-treated cuprophan and cellulose
acetate membranes was examined. One circular disc of mem-
brane was incubated with 200 p1 of NHS at 37°C. Membranes
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Fig. 1. Analysis of proteins eluted from
cuprophan and cellulose acetate.
Membranes were incubated with NHS.
After washing, membrane-associated
proteins were eluted with 1 M NH2OH,
pH 10.5. The samples were dialyzed
and concentrated by lyophilization.
Aliquots of 35 g of protein eluted
from cuprophan (lane g) and cellulose
acetate (lane h) were subjected to SDS-
PAGE under reducing conditions. The
gels were stained with Coomassie blue.
Lane a, isolated C3 (5 pg); lane b,
isolated C3c (12 tg); lane c, isolated
C3dg (9 fig); lane d, isolated factor H
(3 zg); lane e, isolated factor B (3 zg);
lane f, NHS (35 tg). The positions of
the molecular weight standards are
indicated on the left. There were
qualitative and quantitative differences
in the proteins eluted from the two
types of dialysis membranes.
incubated with NHS-EDTA served as controls. After 30 min-
utes, the membrane was washed three times with PBS, and
incubated at 37°C with 200 d of PBS/A containing incremen-
tal concentrations of either radiolabeled factor B or H. After 30
minutes, the membrane was rapidly washed three times with
PBS in the test tube, transferred to a clean tube and membrane-
associated radioactivity was quantified in a gamma counter.
The amount of '251-factor B or H bound was calculated based
on the specific activity of the radiolabeled protein and an Mr of
93 kDa and 150 kDa, respectively. Binding to the NHS-EDTA-
treated membranes was subtracted from binding to NHS-
treated membranes (total binding) to calculate specific binding.
Pilot studies showed that the specific binding of both radio-
labeled factor B and factor H to cuprophan and cellulose
acetate membranes was reversible, and that maximum specific
binding was reached within 20 minutes and remained constant
through 30 minutes of observation.
Protein concentrations
The concentration of protein eluted from the membranes was
determined by Bio-Rad Protein Assay (Bio Rad Laboratories)
using bovine IgG as the standard. The concentrations of puri-
fied C3 [371, factor B [281, factor H [38] and CVF [281 were
determined spectrophotometrically. C3c and C3dg concentra-
tions were estimated using an absorbance coefficient at 280 nm
of 10.0.
Statistical analysis
Results are shown as the mean SEM. Unpaired data were
analyzed by the two-tailed t-test of Student [39]. Linear regres-
sion analysis was performed using the method of least mean
squares. Equilibrium binding of factors B and factor H to
membrane
eluates
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Fig. 2. Western blot of proteins eluted from NHS-treated cuprophan
and cellulose acetate membranes using anti-C3. Lane a, isolated C3 (1
pg); lane b, isolated C3c (12 pg); lane c, NHS (35 pg); lane d,
cuprophan eluate (35 pg); lane e, cellulose acetate eluate (35 rig). The
putative a chain of C3b is a prominent constituent of the cuprophan
eluate, but it is not visible in the cellulose acetate eluate. The a43
fragment of C3c or iC3b (degradation products of C3b) can be seen in
both eluates.
a
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Fig. 3. Western blot of proteins eluted from NHS-treated cuprophan and cellulose acetate membranes using polyclonal anti-H. A. Lane a,
isolated factor H (2 tg); lane b, NHS (35 pg); lane c, cuprophan eluate (35 sg); lane d, cellulose acetate eluate (35 pg). The concentration of factor
H present in the cellulose acetate eluate (lane d) appears similar to that in NHS (lane b), while no factor H antigens are visible in the cuprophan
eluate (lane C). B. In a separate experiment, a greater amount (50 g) of protein was analyzed. Factor H is present in the cuprophan eluate (lane
a); however, the concentration appears to be less than that in the cellulose acetate eluate (lane b).
Fig. 4. A. Western blot of proteins eluted from NHS-
trea ted cuprophan and cellulose acetate membranes
using polyclonal anti-B. Lane a, NHS (35 pg); lane b,
cuprophan eluate (35 pg); lane c, cellulose acetate
eluate (35 pg). The majority of the protein eluted from
cuprophan that expressed factor B antigenicity was in
the form of Bb (lane b) while B and Bb appeared
equally represented in the cellulose acetate eluate (lane
C). B. Western blot of isolated factor B. Purified factor
B (2.7 jig) was incubated with buffer (lane a), with CVF
(lane b), or with CVF and factor D (lane c). Lane d
contained the cellulose acetate eluate (35 pg). These
experiments allow conclusive identification of the bands
representing factor B, Bb and Ba.
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Fig. 5. Binding of radiolabeled factor B to NHS-treated cuprophan and cellulose acetate membranes. Membranes were incubated with NHS or
NHS-EDTA. After washing, the membranes were incubated with incremental concentrations of '251-factor B. The membranes were washed and
factor B binding was quantified based on the radioactivity of the membranes. Non-specific binding (•, membranes incubated with NHS-EDTA)
was subtracted from total binding (A, membranes incubated with NHS) in order to calculate specific binding (0). A. Isotherm of factor B binding
to cuprophan membranes. The results are representative of 5 separate experiments. The shape of the dose-response curve for specific binding is
consistent with a saturable reaction. B. Isotherm for factor B binding to cellulose acetate membranes. The results are representative of 5 separate
experiments. The shape of the dose-response curve for specific binding is consistent with a saturable reaction. Maximum binding, however,
appears to be less than that for cuprophan. C. Analysis by Scatchard's method of the specific binding of factor B to cuprophan (0) and cellulose
acetate (•) membranes. The results were derived from the data depicted in panels A and B (presented simultaneously in the inset). The affinity
constant for '251-factor B binding (the negative of the slope) to the two membranes was similar (3.53 x 106 M for cuprophan compared to 2.61
x 106 M' for cellulose acetate). The maximum binding of factor B (the intercept of the line with the abscissa) to duprophan, however, was
approximately four times greater than that for cellulose acetate.
membranes were analyzed by the method of Scatchard {40].
The affinity constants at equilibrium for factor B (KB) and factor
H (KH) binding to NHS-treated membranes were compared by
using the t-test on the sets of individual values.
Results
Analysis of the proteins eluted from membranes
Following incubation in NHS, membrane-bound proteins
were dissociated with NH2OH at alkaline pH. Approximately
23 times more protein was eluted from the cellulose acetate than
from cuprophan (27.9 5.7 igIpiece vs. 1.2 0.5 /.tg/piece, N
= 5, P < 0.001). Analysis by SDS-PAGE under reducing
conditions (Fig. 1) showed that the proteins eluted from the
cellulose acetate (lane h) were quantitatively and qualitatively
similar to serum proteins (lane f) except that the a chain of C3
was apparently missing from cellulose acetate eluates. In the
cuprophan eluates (lane g), the putative albumin band was
prominent, but the putative heavy and light chains of IgG were
0
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Table 1. Affi
factor H (KH) b
nity constants at equilibrium for factor B (K8) and
inding to cuprophan and cellulose acetate membranes
KB KHa
Cellulose acetate CuprophanCuprophan
4.64
3.53
11.00
4.11
5.31
6.84 1.99
2.61 3,03
9.40 4.64
3.15 4.38
3.87 3.51
2.37
1.74
5,72 1.21 5.17 1,15b 3.09 0.04C
The affinity constants are reported as the mean SEM x 10 M'.
Membranes were incubated with serum and then washed. Binding of
radiolabeled factor B and factor H to the serum-treated membranes was
analyzed by the method of Scatchard.
a Binding of factor H to cellulose acetate membranes did not demon-
strate saturation binding characteristic; therefore analysis by Scath-
chard's method was not possible.b The difference between the KB to cuprophan and cellulose acetate
was not statistically significant (P 0.774).
C The difference between the KH and K8 to cuprophan was not
statistically significant (P = 0.057).
much less conspicuous compared to either serum (lane f) or the
cellulose acetate eluate (lane h). In addition, C3ba was apparent
in the cuprophan eluate but not in serum or the cellulose acetate
eluate.
Membrane-associated proteins expressing C3 antigens were
identified by immunoblotting of the eluates (Fig. 2). In addition
to its degradation fragments (a68 of iC3b and a43 of iC3b or
C3c), the a chain of C3b was conspicuous in the cuprophan
eluate (lane d). In contrast, only degradation fragments of C3b
were observed in the cellUlose acetate eluate (lane e).
Immunoblotting for factor H antigen showed that there was
proportionally more of this APC inhibitory protein in the
cellulose acetate eluate compared to the cuprophan eluate (Fig.
3). Inasmuch as cellulose acetate bound over 20 times more
proteins than did cuprophan, the total amount of factor H
bound to cellulose acetate was much greater than that bound to
cuprophan.
The Western blot of the eluates in which anti-factor B was
used as the primary antibody (Fig. 4A) showed that for cu-
prophan, the majority of the protein expressing factor B anti-
gens was in the form of the enzymatically active Bb fragment
(lane b). In contrast, the cellulose acetate eluate appeared to
contain equivalent amounts of native factor B and Bb (lane c).
In a control experiment to confirm the identity of Bb (M 60
kDa), factor B was incubated with CVF and factor D in the
presence of MgCI2 (Fig. 4B, lane c). Under these conditions,
factor B binds to CVF and is subsequently cleaved by factor D.
In the absence of factor D, no Bb was observed (lane b). The Ba
fragment was also observed in lane c of Fig. 4B. Its absence
from lanes b and c of Fig. 4A indicated that the fragment did not
bind to either membrane.
The presence of C3b and Bb on cuprophan membranes
suggested that residual C3 convertase activity might be present
after exposure to NHS for 30 minutes. To test this hypothesis,
membranes were incubated with NHS. After washing, isolated
C3 was added, and the capacity of the membranes to mediate
C3 activation was assessed by measuring the generation of C3a.
Table 2. Maximum binding of factor B and factor H to cuprophan
and cellulose acetate membranes
Factor B Factor Ha
CuprophanCuprophan Cellulose acetate
1.20 0.20 0.81
1.24 0.29 1.10
1.30 0,42 0.21
1.14 0.26 0.37
1.29 0.34 0.68
1.00
1.34
1.24 0.03 0.30 003b 0.77 0.14C
The results are reported as the mean SEM (pmol/piece of 1 cm
diameter circular membrane). Membranes were incubated with serum
and then washed. Binding of radiolabeled factor B and factor H to the
serum-treated membranes was analyzed by the method of Scatchard.
a Binding of factor H to cellulose acetate membranes did not demon-
strate saturation binding characteristic; therefore analysis by Scatch-
ard's method was not possible.
b The difference between the maximum binding of factor B to
cuprophan and cellulose acetate was statistically significant (P < 0.001).
C Thedifference between the maximum binding of factor H and factor
B to cuprophan was statistically significant (P = 0.027).
Greater than 2.5 times more C3a was present in the supernate of
the serum-treated cuprophan membranes (1677 199 nglml
compared to 608 77 nglml for cellulose acetate, N = 5, P =
0.001).
Analysis of the binding of radiolabeled factor B and factor H
to membranes
The apparent differences in C3b integrity when bound to
cuprophan and cellulose acetate membranes (Fig. 2) prompted
the investigation of the binding of '251-factor B and '251-factor H
to C3b on the two membranes following incubation with NHS.
Binding of factor B to both membranes appeared to be saturable
(Fig. 5 A and B). When the results were analyzed by Scatch-
ard's method, the data points showed a linear relationship that
is consistent with a homogeneous reaction involving a single
class of binding sites. There was no difference between the
affinity constant for factor B binding (KB) to the two mem-
branes (Fig. 5C, Table I). The maximum number of factor B
binding sites (determined by the intercept of the line with the
abscissa) on cuprophan, however, was approximately four
times greater than that on cellulose acetate (Fig. 5C, Table 2).
The isotherm for '251-factor H binding to cuprophan mem-
branes was also consistent with a saturable reaction (Fig. 6A).
Scatchard's analysis indicated the existence of a single class of
binding sites (Fig. 6C). The affinity constant for factor H
binding (KH) to cuprophan membranes was less than the KB
(Table 1) but the difference did not achieve statistical signifi-
cance (P = 0.057). The maximum number of factor H binding
sites was significantly lower than the maximum binding sites for
factor B (Table 2).
The dose-response curve for factor H binding to cellulose
acetate was complex (Fig. 6B). The total binding appeared to
reach a plateau, however, so did the nonspecific binding. As a
result, the specific binding curve appeared biphasic. Inasmuch
as factor H binding did not demonstrate saturation binding
characteristics, analysis by Scatchard's method was invalid.
The results of the studies reported herein indicate that the
greater activation of the APC by cuprophan membranes com-
pared to cellulose acetate membranes is due to the fact that a
greater portion of the C3b that binds to the cuprophan is
protected from inactivation by factor H (Fig. 2). As a result, the
formation and stability of the C3 convertase is favored.
Compared to cuprophan, cellulose acetate membranes bind
much greater amounts of serum proteins, but the C3b that is
bound is rapidly degraded into inactive forms (Fig. 2). The
binding of factor H (Fig. 3), along with other serum proteins,
may create an environment on the membrane that is similar to
that in NHS. Under these circumstances, the presence of
relatively large concentrations of factor H on the membrane
could inhibit C3 convertase formation and facilitate the enzy-
matic degradation of C3b by factor I. That membrane-bound
factor H may function as an inhibitor of APC activity has been
suggested by the recent report of Horstman et al [211. In those
studies, streptococci bearing the M protein were shown to bind
factor H much more avidly than streptococci lacking the M
protein. These results suggested the possibility that inhibition of
APC activity by M-positive streptococci is due to the binding of
factor H to a membrane constituent, thus placing the regulatory
protein in close proximity to cell-bound C3b. Factor H bound to
cellulose acetate membranes may function in an analogous
fashion. The mechanism by which acetylation enhances protein
binding, however, remains to be determined.
The protein expressing factor B antigens on cuprophan
membranes was primarily in the form of Bb, the enzymatic
subunit of the C3 and C5 convertases of the APC (Fig. 3). On
cellulose acetate membranes, native factor B and Bb appeared
to be represented in equivalent amounts. Since cellulose acetate
membranes have bound 23 times more protein than cuprophan
membranes, it appeared that there were more Sb molecules on
cellulose acetate than on cuprophan membranes. The residual
C3 convertase activity on the cuprophan membranes was,
however, approximately three times greater than that of cellu-
lose acetate. These results suggested the majority of the Bb on
cuprophan membranes was associated with C3b and was there-
fore functionally active, while most of the Bb on cellulose
acetate was bound to the membrane but not in association with
C3b.
The efficacy of hydroxylamine at alkaline pH in dissociating
membrane-bound C3 has been previously demonstrated [12, 41]
and was further substantiated by incubating cellulosic mem-
branes with C3-depleted human serum repleted with radiola-
beled C3. The results of these experiments showed that 1 M
hydroxylamine, pH 10.5 removed > 97% of the radiolabeled C3
Fig. 6. Binding of radiolabeled factor H to NHS-treated cuprophan
and cellulose acetate membranes. Membranes were incubated with
NHS or NHS-EDTA, After washing, the membranes were incubated
with incremental concentrations of '251-factor H, the membranes were
washed and factor H binding was quantified based on the radioactivity
of the membranes. Non-specific binding (S, membranes incubated with
NHS-EDTA) was subtracted from total binding (A, membranes incu-
bated with NHS) in order to calculate specific (0) binding. A. Isotherm
of factor H binding to cuprophan membranes. The results are repre-
sentative of seven separate experiments. The shape of the dose-
response curve for specific binding is consistent with a saturable
reaction. B. Isotherm for factor H binding to cellulose acetate mem-
branes. The results are representative of seven separate experiments.
The shape of the dose-response curve for specific binding is inconsis-
tent with a saturable reaction. C. Analysisby Scatchard's method of the
specific binding of factor H to cuprophan membranes (•). The regres-
sion analysis curve was linear suggesting a single class of binding sites
for factor H on the NHS-treated cuprophan membranes. Binding of
factor H to NHS-treated cellulose acetate membranes could not be
analyzed by Scatchard's method because the isotherm did not demon-
strate characteristics of saturation.
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from both cuprophan and cellulose acetate membranes (data
not shown).
In order to determine the efficiency of binding of activated
C3b and to characterize the binding of factor B and factor H to
membrane-bound C3b, attempts were made to deposit C3b onto
cuprophan and cellulose acetate membranes using isolated
complement components. Unlike the situation with erythro-
cytes [35] and numerous other biological surfaces [36], how-
ever, specific binding of C3b to cellulosic membranes was not
observed. These findings are consistent with prevkus observa-
tions that activated C3b does not bind covalently to cellulosic
membranes [12], and indicate that other serum constituents are
required for the binding of activated C3 to occur.
The KB to cuprophan and cellulose acetate was equivalent
(Fig. SC, Table 1), and these values are similar to those reported
for factor B binding to fluid-phase C3b and to C3b on other
particulate surfaces [42]. The maximum number of factor B
binding sites on cuprophan, however was four times greater
than that on cellulose acetate (Fig. SC, Table 2). Since C3b is
the ligand for factor B, these results are consistent with the
anti-C3 Western blot (Fig. 2) which showed more C3b on the
cuprophan eluate. The KH to cuprophan was lower than the K
but the difference was not statistically significant (Table 1). The
maximum number of factor B binding sites, however, was
approximately twice as great as that of factor H binding sites
(Table 2). These results suggest that a portion of the C3b
binding site on cuprophan are inaccessible to binding by factor
H. As a result, these C3b molecules may be protected from
inactivation.
The binding of factor H to NHS-treated cellulose acetate
membranes could not be analyzed by Scatchard's method
because saturation binding characteristics were not observed
(Fig. 6B). The total binding of factor H to cellulose acetate
membranes was greater than that to cuprophan membranes, in
part because the non-specific binding was greater (Fig. 6 A and
B). Nonspecific binding is defined as binding to membranes that
have been incubated with NHS-EDTA. It is possible, however,
that as discussed above, the binding of factor H to the mem-
brane may be of functional importance. Under these circum-
stances, the term non-specific may be inappropriate.
The present in vitro studies demonstrated a difference be-
tween the binding of APC regulatory proteins to cuprophan and
cellulose acetate and provide a plausible explanation for the
difference in complement activation potential between these
two membranes. Conceivably, in the clinical setting, comple-
ment activation on hemodialysis membranes may be influenced
by blood cells and blood flow rates. Further studies aimed at
analyzing the effects of these interactions should be pursued.
Extracorporeal membranes are employed in a variety of
clinical situations. An understanding of the molecular basis by
which their biochemical and biophysical properties influence
bioactive systems should lead to the development of artificial
membranes with improved biocompatibility characteristics.
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